Chart — Med-Surg
COPD vs Asthma Comparison Chart
COPD and asthma are both obstructive pulmonary diseases but differ fundamentally in their pathophysiology, reversibility, patient demographics, and management priorities. This chart provides a side-by-side comparison for clinical differentiation and NCLEX preparation.
Educational use only. Pulmonary diagnoses are confirmed by pulmonary function testing and clinical evaluation. Treatment is provider-ordered and individualized. This chart supports learning, not clinical decision-making. This material supports nursing education and exam review. It is not medical advice and is not a substitute for clinical judgment, institutional policy, or medical direction. Always follow facility protocols and current provider orders.
COPD vs Asthma — Full Comparison
| Feature | COPD | Asthma |
|---|---|---|
| Pathophysiology | Chronic inflammation → airway narrowing + alveolar destruction (emphysema) and/or mucus hypersecretion (chronic bronchitis)Loss of lung elastic recoil → air trapping | Airway hyperresponsiveness + inflammation → bronchoconstriction, mucus, and edemaSmooth muscle hypertrophy with chronic disease |
| Airflow reversibility | Not fully reversible — fixed obstruction; may have partial bronchodilator response | Fully reversible (or near fully) between episodes; normal FEV1 when controlled |
| Typical patient | Older adult (typically > 40), smoker (85–90%), gradual symptom onset over years | Often younger, may have atopy/allergies; symptoms can begin in childhood |
| Triggers | Smoking, respiratory infections, cold air, pollution; exacerbations are progressive | Allergens, cold air, exercise, aspirin/NSAIDs, stress, GERD, respiratory infections |
| Symptoms between episodes | Persistent — dyspnea, productive cough; never fully clears to normal | Absent or minimal — patient may be completely asymptomatic between attacks |
| Assessment findings | Barrel chest, prolonged expirationDiminished breath soundsPursed-lip breathingProductive cough (chronic bronchitis)Accessory muscle use (chronic)Clubbing, cyanosis (advanced) | Expiratory wheeze (may be bilateral)Tachypnea, chest tightnessNon-productive cough (early), productive laterSilent chest = severe, impending failurePulsus paradoxus in severe attack |
| Spirometry (PFTs) | FEV1/FVC < 0.70 after bronchodilator — fixed obstruction | FEV1/FVC < 0.70 during attack; returns to normal after bronchodilator |
| ABG pattern | Chronic resp. acidosis + metabolic compensation (elevated HCO₃, chronically elevated PaCO₂); chronic hypoxemia | Early attack: respiratory alkalosis (hyperventilation, low PaCO₂); severe/late: respiratory acidosis (PaCO₂ rises = impending failure) |
| O₂ target | 88–92% (risk of CO₂ narcosis with higher targets in retainers) | 94–98% (standard target; no hypoxic drive concern) |
| Typical treatments | SABA (rescue), LABA + LAMA (maintenance)Inhaled corticosteroids (ICS) for moderate-severeSmoking cessation (most important modifiable factor)Pulmonary rehabilitationOxygen therapy for resting hypoxemia | SABA (rescue — albuterol); LABA + ICS (maintenance)ICS are mainstay of persistent asthma controlTrigger avoidanceBiologic agents for severe eosinophilic asthmaSystemic steroids for exacerbations |
| Prognosis | Progressive — lung function declines over time; smoking cessation slows decline | Controlled with medications; remission possible in children; may worsen with chronic inflammation |
Key Differentiating Concepts
Reversibility is the Key Distinction
The defining difference between COPD and asthma is reversibility of airflow obstruction. Asthma obstruction reverses with bronchodilators and between attacks. COPD obstruction is fixed — the structural damage to airways and alveoli cannot be fully reversed. This is confirmed by post-bronchodilator spirometry: FEV1/FVC < 0.70 that persists = COPD.
Rising PaCO₂ in Asthma = Emergency
In acute asthma, early hyperventilation causes respiratory alkalosis (low PaCO₂). When PaCO₂ begins to normalize or rise during an attack, the patient is tiring — they can no longer compensate by hyperventilating. A “normal” PaCO₂ in a patient having an acute asthma attack is a warning sign of impending respiratory failure, not reassurance.
Silent Chest in Asthma
In severe asthma, such extreme bronchoconstriction occurs that airflow is too minimal to generate audible wheeze — a “silent chest.” This is a dangerous late finding requiring immediate escalation. The absence of wheeze does not indicate improvement; it may indicate near-complete obstruction.
NCLEX Quick Tips
- COPD = irreversible obstruction. Asthma = reversible obstruction.
- Barrel chest + pursed-lip breathing = emphysema (COPD)
- SpO₂ target in COPD: 88–92%. In asthma: 94–98%.
- Silent chest in asthma = impending respiratory failure — escalate immediately
- Rising PaCO₂ in asthma attack = the patient is tiring — medical emergency
- Most important COPD intervention: smoking cessation (slows disease progression)
- Pursed-lip breathing in COPD: keeps airways open, reduces air trapping
Related Resources
Standards & sources
Fact-checked Jun 21, 2026This page is written to align with Academy of Medical-Surgical Nurses (AMSN) · Current medical-surgical nursing standards. It is an educational summary, not a citation of any single document — always verify specific doses, values, and protocols against current guidelines and your facility policy. How we source content →